Back with a Vengeance: Microvascular Tumor Embolism

      Imaging studies could not capture the source of a 70-year-old woman's pulmonary hypertension and dyspnea. Nine years earlier, she had undergone breast-conserving surgery with axillary nodal dissection, adjuvant chemotherapy, and radiation for cancer of the right breast. At that time, the diagnosis was Stage IIA (pT1cN1aM0). The 1.2-cm tumor was categorized as invasive micropapillary carcinoma, hormone receptor-positive, and human epidermal growth factor receptor 2-negative, and she had 3 positive axillary lymph nodes. Her mammogram and chest X-ray results had been reported as normal as recently as 1 year prior to the present admission. The values of the serum tumor markers cancer antigen 15-3 and carcinoembryonic antigen, at 356 U/mL and 10.4 ng/mL, respectively, were elevated 1 month prior to the present admission. Yet, she had no noticeable signs of recurrence.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to The American Journal of Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Yu M.
        • Stott S.
        • Toner M.
        • Maheswaran S.
        • Haber D.A.
        Circulating tumor cells: approaches to isolation and characterization.
        J Cell Biol. 2011; 192: 373-382
        • Pantel K.
        • Brakenhoff R.H.
        Dissecting the metastatic cascade.
        Nat Rev Cancer. 2004; 4: 448-456
        • Pierga J.Y.
        • Bonneton C.
        • Vincent-Salomon A.
        • et al.
        Clinical significance of immunocytochemical detection of tumor cells using digital microscopy in peripheral blood and bone marrow of breast cancer patients.
        Clin Cancer Res. 2004; 10: 1392-1400
        • De Giorgi U.
        • Valero V.
        • Rohren E.
        • et al.
        Circulating tumor cells and bone metastases as detected by FDG-PET/CT in patients with metastatic breast cancer.
        Ann Oncol. 2010; 21: 33-39
        • Cristofanilli M.
        • Budd G.T.
        • Ellis M.J.
        • et al.
        Circulating tumor cells, disease progression, and survival in metastatic breast cancer.
        N Engl J Med. 2004; 351: 781-791
        • Rai P.R.
        • Cool C.D.
        • King J.A.
        • et al.
        The cancer paradigm of severe pulmonary arterial hypertension.
        Am J Respir Crit Care Med. 2008; 178: 558-564
        • Roberts K.E.
        • Hamele-Bena D.
        • Saqi A.
        • Stein C.A.
        • Cole R.P.
        Pulmonary tumor embolism: a review of the literature.
        Am J Med. 2003; 115: 228-232
        • Soares F.A.
        • Pinto A.P.
        • Landell G.A.
        • de Oliveira J.A.
        Pulmonary tumor embolism to arterial vessels and carcinomatous lymphangitis. A comparative clinicopathological study.
        Arch Pathol Lab Med. 1993; 117: 827-831
        • Chen W.L.
        • Cherng S.C.
        • Hwang W.S.
        • et al.
        Perfusion scan in pulmonary tumor microembolism: report of a case.
        J Formos Med Assoc. 1991; 90: 863-866
        • Shepard J.A.
        • Moore E.H.
        • Templeton P.A.
        • McLoud T.C.
        Pulmonary intravascular tumor emboli: dilated and beaded peripheral pulmonary arteries at CT.
        Radiology. 1993; 187: 797-801
        • McLaughlin V.V.
        • Archer S.L.
        • Badesch D.B.
        • et al.
        • ACCF/AHA
        ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association.
        Circulation. 2009; 119: 2250-2294